Cite
HARVARD Citation
Stefanou, M. et al. (2020). Posterior reversible encephalopathy syndrome in a melanoma patient with dabrafenib and trametinib treatment following immunotherapy. Journal der Deutschen Dermatologischen Gesellschaft. pp. 136-139. [Online].